Enterprise Value
152.9M
Cash
110M
Avg Qtr Burn
-12.09M
Short % of Float
8.86%
Insider Ownership
22.92%
Institutional Own.
69.45%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|